Oxycodone controlled release - Teikoku Seiyaku

Drug Profile

Oxycodone controlled release - Teikoku Seiyaku

Alternative Names: Oxycodone; TK 641

Latest Information Update: 20 May 2017

Price : $50

At a glance

  • Originator Teikoku Seiyaku
  • Class Opioid analgesics; Small molecules
  • Mechanism of Action Opioid mu receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase III Cancer pain

Most Recent Events

  • 01 Aug 2012 Teikoku Seiyaku completed a phase III trial in Cancer pain (JapicCTI-111388)
  • 01 Jan 2011 Phase-III clinical trials in Cancer pain (Treatment-experienced) in Japan (PO) (JapicCTI-111388)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top